Significant differences were observed not only in the prevalence of VCA-IgA (P < 0.001), but also in the prevalence of VCA-IgG and EBNA1-IgG antibodies (P < 0.01) between the 6–10 years old SLE patients and controls. This evidence concerns the gene CD79A and systemic lupus erythematosus.